About CTSUCTSU is part of the Nuffield Department of Population Health, a major section within the Medical Sciences Division of Oxford University, which conducts internationally renowned research into medical treatments and the factors affecting population health worldwide, with a history of high-impact results. CTSU’s work chiefly involves studies of the causes and treatment of “chronic” diseases such as cancer, heart attack or stroke (which, collectively, account for most adult deaths worldwide), although it does also involve some studies of other major conditions in developed and developing countries. |
NewsStatin treatment reduces the risk of cardiovascular disease in womenA large international study showing conclusively that statin treatment reduces the risk of cardiovascular disease in women is published in The Lancet today. Read more in the NDPH news item. Annual Meeting Shows Extent of Damage Caused by SmokingLife line screening's data helps add evidence to shed light on risk caused by silent disease. Oxford University researchers presented data that reveal the extent to which smoking causes silent but deadly damage to health at the annual scientific meeting of the American Heart Association (AHA). Read more in the NDPH news item.
|
Honoraria
Independent ResearchAbout independent research at CTSU
VacanciesSee a list of all available vacancies at CTSU
Seminars |
